Efavirenz as Second-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer

Clinical trial NCT00964171 · COMPLETED

Trial details

NCT number: NCT00964171
Sponsor: Institut Bergonié
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pancreatic Cancer

Start date: 2008-08-01
Primary completion: 2010-07-01
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.